Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Food Effect on PK of NVP-1402
NCT03340480Phase 1Completed
- Sponsor
- NVP Healthcare Co., Ltd.
- Start
- Dec 2017
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of NVP-1402 (2 arms), sponsored by NVP Healthcare Co., Ltd. Primary endpoints: Maximum Plasma Concentration up to 24 hours and Area Under the Curve to Last Measurable Concentration up to 24 hours. Started Dec 2017; status: completed.
02
Drugs
NVP-1402
Beyond the preview
Go deeper on NCT03340480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03340480.